Medicine and Dentistry
COVID-19
100%
Persistent Truncus Arteriosus
95%
Diseases
85%
Bariatric Surgery
81%
Systematic Review
80%
Physical Activity
79%
Maturity Onset Diabetes of the Young
70%
Randomized Controlled Trial
67%
Interstitial Lung Disease
64%
Low and Middle Income Countries
58%
Prevalence
55%
Cross Sectional Study
49%
Idiopathic Pulmonary Fibrosis
49%
Meta-Analysis
47%
Biological Marker
44%
Telemedicine
38%
Health Care Cost
38%
Congenital Malformation
38%
Lung
37%
Diabetes
36%
Roux-en-Y Gastric Bypass
32%
Odds Ratio
29%
Placebo
28%
Quality of Life
28%
Mental Health
25%
Rare Disease
24%
Pediatrics
24%
Health Outcomes
23%
Multiple Chronic Conditions
23%
Pediatric Cardiology
23%
Pulmonary Fibrosis
22%
Public Health
22%
Infection
21%
Clinical Trial
20%
Forced Vital Capacity
19%
Glucagon Like Peptide 1
18%
First Trimester Pregnancy
17%
Echocardiography
17%
Congenital Heart Defect
17%
Sarcopenia
16%
Rheumatoid Arthritis
16%
Inflammatory Arthritis
16%
Cohort Analysis
16%
Logistic Regression Analysis
16%
Proteomics
16%
Skeletal Muscle
16%
Mild Cognitive Impairment
16%
Patient Referral
15%
In Vitro
15%
Comorbidity
15%
Body Mass Index
14%
Pirfenidone
14%
Severe Acute Respiratory Syndrome Coronavirus 2
14%
Chronic Kidney Disease
14%
Obstetrics
14%
Clinician
14%
Gene Linkage
14%
Observational Study
14%
Alcohol Consumption
13%
Adverse Event
13%
Patient with Type 2 Diabetes
13%
Polycystic Ovary Syndrome
13%
Abdominal Obesity
13%
Cardiovascular Disease
13%
Nintedanib
12%
Community-Dwelling Older Adults
12%
Drug Therapy
12%
Medicine
12%
Sleeve Gastrectomy
12%
Gastric Bypass Surgery
12%
Visual Impairment
11%
Methylation
11%
Type 2 Diabetes
11%
Dyspnea
11%
Case-Control Study
11%
Congestive Heart Failure
11%
Obesity Medicine
11%
Accelerometer
11%
Patient with Obesity
11%
Treatment Response
10%
Coughing
10%
Patient Care
10%
Limb
10%
Supplementation
10%
Electrocardiogram
10%
Silo-Filler's Disease
10%
Mediator
10%
Combination Therapy
10%
Sitting
9%
Behavioral Change
9%
Metabolite
9%
Neonate
9%
Gene Expression
9%
Functional Magnetic Resonance Imaging
9%
Health Behavior
9%
Glycemic
9%
Nutrition
9%
Exercise Tolerance
9%
Food Intake
8%
Pathophysiology
8%
Nursing and Health Professions
Pandemic
60%
Systematic Review
55%
Congenital Heart Disease
46%
Diseases
38%
Cross-Sectional Study
33%
Mental Health
31%
Quality of Life
30%
Meta Analysis
29%
Accelerometer
23%
Hemodialysis
23%
Practice Guideline
23%
Nutrition Policy
22%
Patient Referral
21%
Confidence Interval
20%
Health Practitioner
19%
Adolescent
18%
Nurse Midwife
17%
Telemedicine
17%
Electrocardiogram
17%
Teleconsultation
15%
Longitudinal Analysis
15%
Health Care Personnel
13%
Cost Effectiveness Analysis
13%
Medical Student
12%
Biological Marker
11%
Logistic Regression Analysis
11%
Self Care
11%
Prevalence
11%
End Stage Renal Disease
11%
Heart Infarction
10%
Visual Impairment
10%
Rheumatic Disease
10%
Rheumatoid Arthritis
10%
Inflammatory Arthritis
10%
Health Profession
10%
General Practitioner
9%
Health Outcomes
9%
Non Insulin Dependent Diabetes Mellitus
9%
Interstitial Lung Disease
9%
Home Care
8%
Biobank
8%
Checklist
8%
Triage
7%
Congenital Heart Malformation
7%
Cohort Analysis
7%
Infection
7%
Fibrosing Alveolitis
7%
Social Isolation
7%
Acute Coronary Syndrome
6%
Medline
6%
Rare Disease
6%
Problem-Based Learning
6%
Quality Control
6%
Ankle Sprain
6%
Wearables
6%
Abdominal Obesity
6%
Cannabis
6%
Long Term Care
6%
Bariatric Surgery
6%
Self Report
6%
Erectile Dysfunction
6%
Prostate Cancer
6%
Percutaneous Coronary Intervention
6%
World Health Organization
6%
Pilot Study
6%
Waist Circumference
6%
Odds Ratio
6%
Base
6%
Socialized Medicine
5%
Health Care
5%
Thematic Analysis
5%
Heart Disease
5%
Severe Acute Respiratory Syndrome
5%
Economic Evaluation
5%
General Practice
5%
Inflammation
5%
Home Monitoring
5%
Professional Standard
5%
Health Survey
5%
Adjuvant Therapy
5%
Body Mass
5%
Malignant Neoplasm
5%
Comorbidity
5%
Clinical Education
5%
Cardiologist
5%
Life Expectancy
5%
Health Care Planning
5%
Self Evaluation
5%
Pharmacology, Toxicology and Pharmaceutical Science
Diseases
63%
Prevalence
47%
Biological Marker
37%
Fibrosing Alveolitis
35%
Congenital Malformation
32%
Interstitial Lung Disease
27%
Nintedanib
25%
Placebo
25%
Randomized Controlled Trial
23%
Rheumatoid Arthritis
23%
Inflammatory Arthritis
23%
Inflammation
21%
Non Insulin Dependent Diabetes Mellitus
20%
SARS Coronavirus
20%
Pandemic
20%
Infection
17%
Clinical Trial
17%
Lung Fibrosis
17%
Pirfenidone
16%
Cohort Study
15%
Congenital Heart Disease
14%
Observational Study
14%
Multiple Chronic Conditions
13%
Coronavirinae
13%
Amyotrophic Lateral Sclerosis
12%
Adverse Event
12%
Malignant Neoplasm
12%
Case-Control Study
11%
Tolerability
11%
Tumor Necrosis Factor
11%
Remission
10%
Polypharmacy
10%
Cross-Sectional Study
9%
Antidepressant
9%
Coughing
9%
Pharmacotherapy
9%
Glucagon Like Peptide 1 Receptor Agonist
8%
Heart Infarction
8%
Comorbidity
8%
Pharmacovigilance
8%
Drug Development
8%
Liraglutide
8%
Alzheimer's Disease
8%
Cardiovascular Disease
8%
Pathophysiology
7%
Analgesic Agent
7%
Rheumatic Disease
7%
Combination Therapy
7%
Asthma
7%
Cytokine
7%
Morphine
7%
Motor Neuron Disease
7%
Congestive Heart Failure
6%
Congenital Heart Malformation
6%
Dyspnea
6%
Glucocorticoid
6%
Hemodialysis
6%
Agents Acting on the Eye
6%
Cross Sectional Study
6%
Cancer Growth Factor
6%
Biomaterial
6%
Volatile Organic Compound
6%
Hospital Mortality
6%
Acute Myeloid Leukemia
6%
Side Effect
6%
Glucagon-Like Peptide-1
6%
Folic Acid
5%
Chronic Kidney Failure
5%
Kidney Disease
5%
Disease Exacerbation
5%
Antibiotics
5%
Receptor
5%
Autoimmune Disease
5%
Selective Serotonin Reuptake Inhibitor
5%
Prenatal Exposure
5%
Adverse Outcome
5%